Abstract
Hypertension and cancer are both common disease states due to the aging of the population and the advances in medical treatment which result in increased survival of cancer patients today. More patients with cancer; therefore, present with hypertension, which is attributed to different factors, including genetics and age as well as the type of tumor and cancer-related treatments. Given the increased cardiovascular and mortality risk related to hypertension, it is important to appropriately identify and treat hypertension, particularly in the population of vulnerable cancer patients. In this article we discuss the epidemiology, different etiologies, and approaches to the management of hypertension in cancer patients.
| Original language | English |
|---|---|
| Pages (from-to) | 165-169 |
| Number of pages | 5 |
| Journal | Israel Medical Association Journal |
| Volume | 24 |
| Issue number | 3 |
| State | Published - 1 Mar 2022 |
Keywords
- cancer
- chemotherapy
- hypertension
- vascular endothelial growth factor (VEGF) inhibitors
ASJC Scopus subject areas
- General Medicine
